BRUSSELS, June 4 (Reuters) - The European Union has submitted to the World Trade Organization a plan it believes will more effectively broaden supply of COVID-19 vaccines than the intellectual property (IP) rights waiver backed by the United States.
India, South Africa and dozens of developing countries are demanding an IP rights waiver for COVID-19 vaccines and other treatments to address what they say is a "staggering inequity" in access to what they argue should be global public goods.
The European Commission, which oversees trade policy for the 27-nation EU, said on Friday it had submitted an alternative, stressing limits on export restrictions and existing WTO rules allowing countries to grant licences to producers. (Reporting by Philip Blenkinsop)
Our Standards: The Thomson Reuters Trust Principles.